Logo image of HSIC

HENRY SCHEIN INC (HSIC) Stock Price, Forecast & Analysis

USA - NASDAQ:HSIC - US8064071025 - Common Stock

63.2 USD
+0.3 (+0.48%)
Last: 10/31/2025, 8:00:01 PM
63.2 USD
0 (0%)
After Hours: 10/31/2025, 8:00:01 PM

HSIC Key Statistics, Chart & Performance

Key Statistics
Market Cap7.66B
Revenue(TTM)12.77B
Net Income(TTM)389.00M
Shares121.27M
Float102.46M
52 Week High82.49
52 Week Low60.56
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)4.66
PE13.56
Fwd PE11.88
Earnings (Next)11-04 2025-11-04/bmo
IPO1995-11-03
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Distributors


HSIC short term performance overview.The bars show the price performance of HSIC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -2 -4 -6

HSIC long term performance overview.The bars show the price performance of HSIC in the last 1, 2 and 3 years. 1 year 2 years 3 years -2 -4 -6 -8 -10

The current stock price of HSIC is 63.2 USD. In the past month the price decreased by -5.71%. In the past year, price decreased by -10.19%.

HENRY SCHEIN INC / HSIC Daily stock chart

HSIC Latest News, Press Relases and Analysis

HSIC Competitors/Peers

The largest stocks on the US markets in the "Health Care Distributors" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
MCK MCKESSON CORP 24.23 100.91B
COR CENCORA INC 21.81 65.49B
CAH CARDINAL HEALTH INC 21.41 45.32B
AHCO ADAPTHEALTH CORP 29 1.22B
AHG AKSO HEALTH GROUP N/A 889.76M
OMI OWENS & MINOR INC 2.72 306.64M
WGRX WELLGISTICS HEALTH INC N/A 63.91M
ATPC AGAPE ATP CORP N/A 60.01M
COSM COSMOS HEALTH INC N/A 24.47M
VRAX VIRAX BIOLABS GROUP LTD N/A 2.44M
POM POMDOCTOR LTD - ADR N/A 640.76M

About HSIC

Company Profile

HSIC logo image Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.

Company Info

HENRY SCHEIN INC

135 Duryea Rd

Melville NEW YORK 11747 US

CEO: Stanley M. Bergman

Employees: 25000

HSIC Company Website

HSIC Investor Relations

Phone: 16318435500

HENRY SCHEIN INC / HSIC FAQ

Can you describe the business of HENRY SCHEIN INC?

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.


Can you provide the latest stock price for HENRY SCHEIN INC?

The current stock price of HSIC is 63.2 USD. The price increased by 0.48% in the last trading session.


What is the dividend status of HENRY SCHEIN INC?

HSIC does not pay a dividend.


How is the ChartMill rating for HENRY SCHEIN INC?

HSIC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Would investing in HENRY SCHEIN INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on HSIC.


What is HENRY SCHEIN INC worth?

HENRY SCHEIN INC (HSIC) has a market capitalization of 7.66B USD. This makes HSIC a Mid Cap stock.


HSIC Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

HSIC Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to HSIC. HSIC has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HSIC Financial Highlights

Over the last trailing twelve months HSIC reported a non-GAAP Earnings per Share(EPS) of 4.66. The EPS increased by 8.12% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.05%
ROA 3.57%
ROE 11.29%
Debt/Equity 0.87
Chartmill High Growth Momentum
EPS Q2Q%-10.57%
Sales Q2Q%3.32%
EPS 1Y (TTM)8.12%
Revenue 1Y (TTM)2.29%

HSIC Forecast & Estimates

23 analysts have analysed HSIC and the average price target is 74.93 USD. This implies a price increase of 18.55% is expected in the next year compared to the current price of 63.2.

For the next year, analysts expect an EPS growth of 3.75% and a revenue growth 1.75% for HSIC


Analysts
Analysts71.3
Price Target74.93 (18.56%)
EPS Next Y3.75%
Revenue Next Year1.75%

HSIC Ownership

Ownership
Inst Owners99.98%
Ins Owners0.77%
Short Float %8.6%
Short Ratio5.96